Stiffler Search Group

Pfizer's Lipitor Causing Major Shifts in the Market

Dec 1, 2011 @ 04:46 PM — by Dan Stiffler | Comments (0)
Tagged with: Changes | Pharmaceuticals | Cardiology |

Pfizer recently lost patent protection on its lead drug, Lipitor.  In 2010 Lipitor had sales of $10.7B, which represented 15.8% of Pfizer's revenue.  The ramifications will be widespread.